Amniotic Membrane Market by Type and Geography - Forecast and Analysis 2020-2024

Global Amniotic Membrane Market

About this market

Technavio’s amniotic membrane market analysis considers sales from cryopreserved amniotic membrane and dehydrated amniotic membrane types. Our study also finds the sales of amniotic membrane in Asia, Europe, North America, and ROW. In 2019, the cryopreserved amniotic membrane segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as increased coverage of cryopreserved products in reimbursement schemes of governments will play a significant role in the cryopreserved amniotic membrane segment to maintain its market position. Also, our global amniotic membrane market report looks at factors such as extensive use of amniotic membrane transplantation in ophthalmic surgeries, high demand for amniotic membrane in wound repair and reconstruction, and rising demand for biocompatible scaffolds. However, a limited supply of amniotic membranes, the presence of stringent regulations, and issues related to preservations and contamination may hamper the growth of the amniotic membrane industry over the forecast period.

Global Amniotic Membrane Market

Overview

Rising demand for biocompatible scaffolds

Amniotic membranes have become essential components in tissue engineering-based research and treatment procedures that incorporate the use of these biocompatible membranes as a scaffold. The increasing demand for naturally derived materials in tissue scaffolding has helped surge the demand for amniotic membranes. These membranes have a specialized structure and show substantial biological viability (low immunogenicity, anti-inflammatory, anti-fibrosis, and reasonable mechanical property) that makes them an ideal candidate for creating bio-scaffolds. The increasing demand for bio-scaffolds in repair and regenerative therapies for the treatment of bone, cartilage, ligament, skin, vascular tissues, neural tissues, and skeletal muscles will lead to the expansion of the global amniotic membrane market at a CAGR of over 13% during the forecast period.

Rise in the development of new applications through research

Intense growth in government funding and research activities in the global amniotic membrane market has resulted in the development of potential applications for amniotic membranes that are expected to find significant adoption in the coming years. For instance, amniotic membrane-based therapies have become an integral part of regenerative medicines. Moreover, advances in tissue preservations have resulted in the pipeline development of amniotic membranes with new preservation technologies such as viable lyopreserved human amniotic membrane (VLAM) that claims improved benefits in diabetic wound treatments and longer shelf life. Other potential developments under research include the use of amniotic membranes in tissue remodeling (denuded amniotic membrane), anti-cancer therapy, and lower nasal reconstruction. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global amniotic membrane market during the forecast period 2020-2024, click here.

Competitive Landscape

With the presence of several major players, the global amniotic membrane market is fragmented. Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading amniotic membrane manufacturers, that include Celularity Inc., Human Regenerative Technologies LLC, Integra LifeSciences Holdings Corp., Katena Products Inc., MiMedx Group Inc., NuVision Biotherapies Ltd., Orthofix Medical Inc., Stryker Corp., Surgenex LLC, and TissueTech Inc.

Also, the amniotic membrane market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.


PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
2.1 Preface
2.2 Preface
2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
Market ecosystem
Market characteristics
Market segmentation analysis
PART 04: MARKET SIZING
Market definition
Market sizing 2019
Market size and forecast 2019-2024
Market Outlook
PART 05: FIVE FORCES ANALYSIS
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition
PART 06: MARKET SEGMENTATION BY TYPE
Market segmentation by type
Comparison by type
Cryopreserved amniotic membrane - Market size and forecast 2019-2024
Dehydrated amniotic membrane - Market size and forecast 2019-2024
Market opportunity by type
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2019-2024
Europe - Market size and forecast 2019-2024
Asia - Market size and forecast 2019-2024
ROW - Market size and forecast 2019-2024
Key leading countries
Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
Market drivers
Market challenges
PART 11: MARKET TRENDS
Growing reimbursement coverage for new products
Rise in development of new applications through research
Industry consolidation through mergers and acquisitions
PART 12: VENDOR LANDSCAPE
Overview
Landscape disruption
Competitive scenario
PART 13: VENDOR ANALYSIS
Vendors covered
Vendor classification
Market positioning of vendors
Celularity Inc.
Human Regenerative Technologies LLC
Integra LifeSciences Holdings Corp.
Katena Products Inc.
MiMedx Group Inc.
NuVision Biotherapies Ltd.
Orthofix Medical Inc.
Stryker Corp.
Surgenex LLC
TissueTech Inc.
PART 14: APPENDIX
Research methodology
List of abbreviations
Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO
Exhibit 01: Global pharmaceuticals market
Exhibit 02: Segments of global pharmaceuticals market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendor offerings
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2019
Exhibit 18: Type - Market share 2019-2024 (%)
Exhibit 19: Comparison by type
Exhibit 20: Cryopreserved amniotic membrane - Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Cryopreserved amniotic membrane - Year-over-year growth 2020-2024 (%)
Exhibit 22: Dehydrated amniotic membrane - Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Dehydrated amniotic membrane - Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by type
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
Exhibit 30: Europe - Market size and forecast 2019-2024 ($ millions)
Exhibit 31: Europe - Year-over-year growth 2020-2024 (%)
Exhibit 32: Asia - Market size and forecast 2019-2024 ($ millions)
Exhibit 33: Asia - Year-over-year growth 2020-2024 (%)
Exhibit 34: ROW - Market size and forecast 2019-2024 ($ millions)
Exhibit 35: ROW - Year-over-year growth 2020-2024 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Impact of drivers and challenges
Exhibit 39: Vendor landscape
Exhibit 40: Landscape disruption
Exhibit 41: Vendors covered
Exhibit 42: Vendor classification
Exhibit 43: Market positioning of vendors
Exhibit 44: Celularity Inc. - Vendor overview
Exhibit 45: Celularity Inc. - Business segments
Exhibit 46: Celularity Inc. - Organizational developments
Exhibit 47: Celularity Inc. - Key customers
Exhibit 48: Human Regenerative Technologies LLC - Vendor overview
Exhibit 49: Human Regenerative Technologies LLC - Product segments
Exhibit 50: Human Regenerative Technologies LLC - Key offerings
Exhibit 51: Integra LifeSciences Holdings Corp. - Vendor overview
Exhibit 52: Integra LifeSciences Holdings Corp. - Business segments
Exhibit 53: Integra LifeSciences Holdings Corp. - Organizational developments
Exhibit 54: Integra LifeSciences Holdings Corp. - Geographic focus
Exhibit 55: Integra LifeSciences Holdings Corp. - Segment focus
Exhibit 56: Integra LifeSciences Holdings Corp. - Key offerings
Exhibit 57: Katena Products Inc. - Vendor overview
Exhibit 58: Katena Products Inc. - Product segments
Exhibit 59: Katena Products Inc. - Organizational developments
Exhibit 60: Katena Products Inc. - Key offerings
Exhibit 61: MiMedx Group Inc. - Vendor overview
Exhibit 62: MiMedx Group Inc. - Business segments
Exhibit 63: MiMedx Group Inc. - Organizational developments
Exhibit 64: MiMedx Group Inc. - Key offerings
Exhibit 65: NuVision Biotherapies Ltd. - Vendor overview
Exhibit 66: NuVision Biotherapies Ltd. - Business segments
Exhibit 67: NuVision Biotherapies Ltd. - Organizational developments
Exhibit 68: NuVision Biotherapies Ltd. - Key offerings
Exhibit 69: Orthofix Medical Inc. - Vendor overview
Exhibit 70: Orthofix Medical Inc. - Business segments
Exhibit 71: Orthofix Medical Inc. - Organizational developments
Exhibit 72: Orthofix Medical Inc. - Geographic focus
Exhibit 73: Orthofix Medical Inc. - Segment focus
Exhibit 74: Orthofix Medical Inc. - Key offerings
Exhibit 75: Stryker Corp. - Vendor overview
Exhibit 76: Stryker Corp. - Business segments
Exhibit 77: Stryker Corp. - Organizational developments
Exhibit 78: Stryker Corp. - Geographic focus
Exhibit 79: Stryker Corp. - Segment focus
Exhibit 80: Stryker Corp. - Key offerings
Exhibit 81: Surgenex LLC - Vendor overview
Exhibit 82: Surgenex LLC - Product segments
Exhibit 83: Surgenex LLC - Key offerings
Exhibit 84: TissueTech Inc. - Vendor overview
Exhibit 85: TissueTech Inc. - Business segments
Exhibit 86: TissueTech Inc. - Organizational developments
Exhibit 87: TissueTech Inc. - Key offerings
Exhibit 88: Validation techniques employed for market sizing
Exhibit 89: Definition of market positioning of vendors

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook